机译:Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial
Univ Lorraine, Reg Univ Hosp Nancy, Natl Inst Hlth & Med Res,Initiat Cardiovasc & Ren, Ctr Clin;
Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA;
Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Glasgow, Lanark, ScotlandUniv Minnesota, Dept Cardiovasc Med, Minneapolis, MN USAUniv Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, NetherlandsCopenhagen Univ Hosp, Rigshosp, Copenhagen, DenmarkUniv Glasgow, Robertson Inst, Biostat & Clin Trials Unit, Glasgow, Lanark, ScotlandUniv Montreal, Montreal Inst Cardiol, Montreal, PQ, CanadaBaylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Dallas, TX USAMed Univ South Carolina, Charleston, SC 29425 USANovartis, E Hanover, NJ USANorthwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Chicago, IL 60611 USAUniv Minnesota, Minneapolis VA Ctr Care Delivery & Outcomes Res, Minneapolis, MN USA;
Serum potassium; Heart failure with preserved ejection fraction; Outcomes; Sacubitril; valsartan;